Ayala Pharmaceuticals Inc (ADXS) Return on Assets ROA from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ayala Pharmaceuticals Inc   (ADXS)


Ayala Pharmaceuticals Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Ayala Pharmaceuticals Inc 's ROA in the fourth quarter of 2023?
Ayala Pharmaceuticals Inc recorded a cumulative net loss of $-48 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -346%.

However, within the Healthcare sector 1127 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from 5243 to 5851.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Total Assets Change 107.52 % -74.92 % -59.63 % -45.78 % -82.82 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -48 -33 -30 -29 -24
Return On Assets (TTM) -346 % -282.35 % -183.21 % -136 % -93.6 %
ADXS's Total Ranking # 5851 # 5243 # 5242 # 5294 # 5924
Total Assets (TTM) in million 17 7 12 20 8
Seq. Total Assets Change 154.9 % -46.47 % -40.26 % 154.61 % -69.19 %
Seq. Net Income Change - - - - -

ADXS's 5 Years Annual ROA >> Back to ADXS Management Effectiveness >> Compare ADXS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 555
Sector # 1128
Overall # 5718

Return On Assets Statistics
High Average Low
-25.48 %
-107.22 %
-394.7 %
(Apr 30 2022)   (Apr 30 2013)





Financial Statements
Ayala Pharmaceuticals Inc 's Assets $ 17 million ADXS's Balance sheet
Ayala Pharmaceuticals Inc 's Income $ -25 million Quarterly ADXS's Income Statement
ADXS's Income by Division See ADXS's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Oct 31 2022)
FY 2022		 (Oct 31 2021)
FY 2021		 (Oct 31 2020)
FY 2020		 (Oct 31 2019)
FY 2019
Y / Y Total Assets Change -36.06 % -44.57 % 31.76 % -21.55 % -27.32 %
Total Assets in million 17 26 47 36 45
Y / Y Net Income Change - - - - -
Net Income in million -48 -14 -18 -26 -17
Annual Return On Assets -289.96 % -55.38 % -38.18 % -74.55 % -36.71 %

ADXS's 5 Years Annual ROA >> Back to ADXS Management Effectiveness >> Compare ADXS ROA to its Competitors



More Return On Assets Ratios
ADXS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ADXS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ADXS's Competitors
Subscribers only: Roa for Ayala Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for ADXS's Customers

You may also want to know
ADXS's Roi ADXS's Inventory Turnover Ratio ADXS's Growth Rates ADXS's Dividend Comparisons
ADXS's Profitability Ratios ADXS's Asset Turnover Ratio ADXS's Dividend Growth
ADXS's Roe ADXS's Valuation Ratios ADXS's Financial Strength Ratios ADXS's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector ROA

Date modified: 2026-09-08T15:11:19+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.